Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06170398
Other study ID # RC31/22/0322
Secondary ID 2023-A01856-39
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 2024
Est. completion date January 2026

Study information

Verified date December 2023
Source University Hospital, Toulouse
Contact Yohan Gallois, Dr
Phone 05-61-77-77-04
Email gallois.y@chu-toulouse.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research aims at assessing the validity of three different electro-physiological tests (Vestibular Evoked Myogenic Potentials, WideBand Tympanometry, Electrocochleography) used in the investigation of the symptoms severity in the case of superior semi-circular canal dehiscence syndrome.


Description:

Superior semi-circular canal dehiscence (SCD) syndrome can associate several cochlear and vestibular symptoms. Recent systematic reviews identified pulsatile tinnitus, autophony, sound-induced and pressure-induced vertigo as most specific signs of SCD. These signs are rarely all present and the symptomatology remains highly variable from a patient to another, with frequent though less evocative symptoms such as dizziness or ear pressure. A surgical treatment may be proposed when the symptoms become significantly incapacitating. Unfortunately to date, there is no objective marker of this severity and all surgical decisions rely on the importance of patients' complaints. High Resolution Computed Tomography (HRCT) of the temporal bone can confirm the diagnosis. Electro-physiological investigations such as Vestibular Evoked Myogenic potentials (VEMPs) have also been extensively described in the diagnosis of SCD but they have been reported as independent from the symptoms severity. Wideband tympanometry (WBT) and Electrocochleography (EcoG) have only been studied in few reports but the latter appears as a promising tool in the assessment of the symptoms because it explores inner ear biomechanics, directly involved in the pathophysiology of this condition.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 115
Est. completion date January 2026
Est. primary completion date January 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - confirmed unilateral SCD (using specific HRCT settings and reconstructions) with or without SCD symptoms - if present, SCD symptoms should be stable - patients understanding and reading french - affiliated to social security. Exclusion Criteria: - bilateral confirmed SCD - doubtful SCD - other otologic or neurotologic condition that might mimick SCD symptomatology : middle ear conditions, Meniere disease, vestibular migraine

Study Design


Related Conditions & MeSH terms

  • Superior Semicircular Canal Dehiscence

Intervention

Diagnostic Test:
Wideband tympanometry
Wideband tympanometry
Electrocochleography
Electrocochleography
Vestibular Evoked Myogenic potentials
Vestibular Evoked Myogenic potentials

Locations

Country Name City State
France CHU Toulouse Toulouse

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Toulouse

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary EcoG validity - pulsatile tinnitus the validity of EcoG will be assessed by the correlation between the alteration of the summating potential/action potential ratio and symptom severity (pulsatile tinnitus) assessed by a visual analogue scale (0 to 10) 30 day
Primary EcoG validity - autophony the validity of EcoG will be assessed by the correlation between the alteration of the summating potential/action potential ratio and symptom severity (autophony) assessed by a visual analogue scale (0 to 10) 30 day
Primary EcoG validity - dizziness induced by loud sounds the validity of EcoG will be assessed by the correlation between the alteration of the summating potential/action potential ratio and symptom severity (dizziness induced by loud sounds) assessed by a visual analogue scale (0 to 10) 30 day
Primary EcoG validity - dizziness induced by pressure changes the validity of EcoG will be assessed by the correlation between the alteration of the summating potential/action potential ratio and symptom severity (dizziness induced by pressure changes) assessed by a visual analogue scale (0 to 10) 30 day
See also
  Status Clinical Trial Phase
Withdrawn NCT01727544 - Vestibular Function Outcome After Cartilage Cap Occlusion Surgery Phase 0